Analysis and experimental validation of disulfidptosis related genes solute carrier family 3 member 2 (SLC3A2) in endometrial cancer

Bibliographic Details
Title: Analysis and experimental validation of disulfidptosis related genes solute carrier family 3 member 2 (SLC3A2) in endometrial cancer
Authors: Bo Wang, Wantong Wang, Yuting Wang, Xin Wen, Zihao Wang, Hongrui Leng, Fanfei Kong, Xiaoxin Ma
Source: Cancer Cell International, Vol 24, Iss 1, Pp 1-13 (2024)
Publisher Information: BMC, 2024.
Publication Year: 2024
Collection: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
LCC:Cytology
Subject Terms: Endometrial carcinoma (EC), Disulfidptosis-related genes (DRGs), Prognostic model, Tumor microenvironment (TME), Carrier family 3 member 2 (SLC3A2), Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Cytology, QH573-671
More Details: Abstract Disulfidptosis, a novel cell death paradigm triggered by disulfide stress, remains underexplored, particularly its implications for endometrial cancer (EC). This study focused on the prognostic significance of disulfidptosis-related genes (DRGs) in EC, highlighting the pivotal role of SLC3A2. To predict EC patient outcomes, we developed a model centered on DRGs, employing LASSO-Cox regression for its construction. The model revealed a strong correlation between DRG risk score, gene set enrichment analysis (GSEA), single-sample GSEA (ssGSEA), clinical characteristics, the tumor microenvironment (TME), and the response to immunotherapy. Key genes were pinpointed using random forest maps. To establish SLC3A2's oncogenic effects in EC, we conducted comprehensive studies including apoptosis, cell cycle, TRANSWELL, CCK-8, and tumor xenograft assays. SLC3A2 expression was further confirmed via qRT-PCR. The impact of SLC3A2 on EC's malignant behavior was corroborated through both in vitro and in vivo experiments.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1475-2867
Relation: https://doaj.org/toc/1475-2867
DOI: 10.1186/s12935-024-03560-6
Access URL: https://doaj.org/article/5bf759e4c99f4091a2f3132b2483576b
Accession Number: edsdoj.5bf759e4c99f4091a2f3132b2483576b
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:14752867
DOI:10.1186/s12935-024-03560-6
Published in:Cancer Cell International
Language:English